Healthcare - Biotechnology - NASDAQ - US
$ 31.44
-4.35 %
$ 2.98 B
Market Cap
-20.96
P/E
Price Target
Average
45.52%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
28.10%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Edgewise Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for EWTX of $45.8 , with forecasts ranging from a low of $42 to a high of $51 .
EWTX Lowest Price Target
Wall Street Target
42 USD
33.59%
EWTX Average Price Target
Wall Street Target
45.8 USD
45.52%
EWTX Highest Price Target
Wall Street Target
51 USD
62.21%
REVENUE FORECAST
Revenue Forecast Chart EWTX
EBIT FORECAST
EBIT Forecast Chart EWTX
NET INCOME FORECAST
Net Income Chart EWTX